SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily a member 4 (SMARCA4; BRG1) BriefCommunication Pages: 193 - 193
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily a member 4 (SMARCA4; BRG1) BriefCommunication Pages: 198 - 198
Mycobacterium tuberculosis transmembrane serine/threonine-protein kinase B (pknB) BriefCommunication Pages: 204 - 204
Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2; NRF2); heme oxygenase decycling 1 (HMOX1; HO-1; Hsp32) BriefCommunication Pages: 205 - 205
Diagnosing and monitoring treatment responses in patients with Niemann-Pick disease type C1 (NPC1) using fluorescence-based volumetric measurement of lysosomes BriefCommunication Pages: 206 - 206
Screening antimetastatic compounds using microfluidic-based tracking of cell migration BriefCommunication Pages: 207 - 207
Bone marrow niche–sensitizing chemotherapy to enhance antibody-based acute lymphoblastic leukemia (ALL) elimination BriefCommunication Pages: 208 - 208
Improved brain delivery of anti–transferrin receptor (TFRC; TFR)-containing antibodies by reducing TFRC affinity BriefCommunication Pages: 209 - 209
Inducing multipotent progenitor cells from keratinocytes by depleting the tumor protein p63 (TP63; p63) ΔNp63 isoform or DGCR8 microprocessor complex subunit (DGCR8) BriefCommunication Pages: 210 - 210
Intracellularly expressed antibodies linked to the E3 ubiquitin ligase domain of STIP1 homology and U-box containing protein 1 (STUB1; CHIP) to enable targeted protein degradation BriefCommunication Pages: 211 - 211
Viral insertion of inducible aptazymes to improve the safety of oncolytic viral therapy BriefCommunication Pages: 213 - 213
A cytosine methylation signature that predicts overall survival in acute myelogenous leukemia (AML) BriefCommunication Pages: 214 - 214